Your browser does not support JavaScript!

回首頁 ♦學校首頁

  
  • p3
  • 22
  • 11
  • 0071
  • pp
  • 005
  • 004
  • p3
  • 22
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
 

 

文獻發表

【期刊論文】

  1. SF Yang, MF Hou, FM Chen, OY Fu, YC Wu, CY Chai, YT Yeh (corresponding). Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy. (BMC Cancer. 2016 Jan 14; 16(1):20.)
  2. CJ Yang, YP Liu, HY Dai, YL Shiue, CJ Tsai, MS Huang*, YT Yeh* (co-corresponding). Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer. (Oncotarget. 2015 Oct 6; 6(30):30263-76.)
  3. FM Chen, YT Ting, ZF Chen, MF Hou*, YT Yeh* (co-corresponding). Circulating miR-133a as diagnostic and prognostic biomarker for Taiwanese breast cancer. (The breast. 10.1016/S0960-9776(15)70303-6.)
  4. SN Wang, KT Lee, CJ Tsai, YJ Chen and YT Yeh (corresponding). Dullaart RP et al. Research update for articles published in EJCI in 2012. (Eur J Clin Invest. 2012 Dec; 42(12):1295-301.)
  5. SN Wang, KT Lee, CJ Tsai, YJ Chen and YT Yeh (corresponding). Phosphorylated p38 and JNK MAPK Proteins in Hepatocellular Carcinoma. (European Journal of Clinical Investigation. 2012 Dec; 42(12):1295-301.)
  6. SN Wang, SF Yang, HH Tsai, KT Lee, YT Yeh (corresponding). Increased adiponectin associated with poor survival in hepatocellular carcinoma. (JOURNAL OF GASTROENTEROLOGY. 2014 Sep; 49(9):1342-51.)
  7. YT Yeh (first author), H Yeh, SH Su, JS Lin, KJ Lee, HW Shyu, ZF Chen, SY Huang, SJ Su. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations. (Free Radical Biology & Medicine. 2014 Sep; 74:1-13.)
  8. SF Yang, CW Chang, RJ Wei, YL Shiue, SN Wang*, YT Yeh* (co-corresponding). Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma. (BioMed Research International. 2014; 2014:153867.)
  9. HY Dai, CY Chien, YT Yeh (corresponding). Histone deacetylase 6 promotes a ligand-independent activation of EGFR signaling in hepatocellular carcinoma. (Journal Of Hepatology. 2014 Apr; 60:1-S533)
  10. YT Yeh (first author, corresponding), HY Dai, CY Chien. Amplification of MPZL1/PZR gene in hepatocellular carcinoma. (Hepatobiliary Surgery and Nutrition. 2014 Apr; 3(2):87-90.)
  11. SH Su, HW Shyu, YT Yeh, KM Chen, H Yeh, SJ Su. Caffeine inhibits adipogenic differentiation of primary adipose-derived stem cells and bone marrow stromal cells. (Toxicology in Vitro. 2013 Sep; 27(6):1830-7.)
  12. JH Su, YC Chen, ES Mohamed, YC Du, CW Su, CW Tsao, LL Liu, Y Chou, WB Chang, YD Su, MY Chiang, YT Yeh, MC Lu. Towards the small and the beautiful: a Small Dibromotyrosine Derivative from Pseudoceratina sp. Sponge Exhibits Potent Apoptotic Effect through Targeting IKK/NFκB Signaling Pathway. (Marine drugs. 2013 Aug 26; 11(9):3168-85.)
  13. SJ Su*, YT Yeh* (co-first author), SH Su, KL Chang, HW Shyu, KM Chen and H Yeh. Biochanin A promotes osteogenic but inhibits adipogenic differentiation: Evidence with primary adipose-derived stem cells. (Evidence-Based Complementary and Alternative Medicine. 2013; 2013:846039.)
  14. KJ Huang, YC Chen, ES Mohamed, YC Du, JH Su, CW Tsao, WH Yen, WB Chang, YD Su, YT Yeh, MC Lu. 5-Episinuleptolide Acetate, a Norcembranoidal Diterpene from the Formosan Soft Coral Sinularia sp., Induces Leukemia Cell Apoptosis through Hsp90 Inhibition. (Molecules. 2013 Mar 4; 18(3):2924-33.)
  15. MF Hou, FM Chen, YT Yeh (corresponding). Potential role of activated mitogen activated protein kinase kinase 4 in breast cancer. (The Breast. 2003 Apr 3; 22(13):2034-44.)
  16. SJ Su, KL Chang, SH Su, YT Yeh, HW Shyu, KM Chen. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. (International Journal of Food Sciences and Nutrition. 2013 Jun; 64(4):429-36.)
  17. SJ Su, YT Yeh, HW Shyu. The Preventive Effect of Biochanin A on Bone Loss in Ovariectomized Rats: Involvement in Regulation of Growth and Activity of Osteoblasts and Osteoclasts. (Evidence-Based Complementary and Alternative Medicine. 2013; 2013:594857.)
  18. YT Yeh (first author), CW Chang, RJ Wei, and SN Wang. Progesterone and related compounds in hepatocellular carcinoma: Basic and clinical aspects. (BioMed Research International. 2013; 2013:290575.)
  19. MF Hou, CW Chang, FM Chen, SN Wang, SF Yang, PH Chen, JH Su, YT Yeh (corresponding). Decreased total MKP-1 protein levels predict poor prognosis in breast cancer. (World Journal of Surgery. 2012 Aug; 36(8):1922-32.)
  20. YT Yeh* (first author), MJ Chen*, KT Lee, CJ Tsai, HH Lee, SN Wang. The promoting effect of adiponectin in hepatocellular carcinoma. (JOURNAL OF SURGICAL ONCOLOGY. 2012 Aug 1; 106(2):181-7.)
  21. FM Chen, HW Chang, SF Yang, YF Huang, PY Nien, YT Yeh (corresponding), MF Hou. The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer. (Experimental & Molecular Medicine. 2012 May 31; 44(5):356-62.)
  22. YT Yeh* (first author), KT Lee*, CJ Tsai, YJ Chen, SN Wang. Prolactin Promotes Hepatocellular Carcinoma through Janus Kinase 2. (WORLD JOURNAL OF SURGERY. 2012 May; 36(5):1128-35.)
  23. ML Chen, CY Chai, KT Yeh, SN Wang, CJ Tsai, YT Yeh* (co-corresponding), SF Yang*. Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma. (Disease markers. 2011; 30(6):325-33.)
  24. SF Yang, JY Yang, CH Huang, SN Wang, CP Lu, CJ Tsai, CY Chai, YT Yeh (corresponding). Increased Caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma. (Pathology. 2010; 42(5):438-45.)
  25. SN Wang*, YT Yeh* (co-first author), ST Wang, YL Chen, SC Chuang, CG Ker, KT Lee. Decreased retinol binding protein 4 concentrations areassociated with cholesterol gallstone disease. (JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION. 2010 Jun; 109(6):422-9.)
  26. SN Wang*, YT Yeh* (co-first author), ST Wang, KT Lee. Visfatin - a proinflammatory adipokine - in gallstone disease. (American Journal of Surgery. 2010 Apr; 199(4):459-65.)
  27. WW Su, KT Lee, YT Yeh, MS Soon, CL, Wang, ML Yu, SN Wang. Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlationstudy. (JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2010; 24(3):195-200.)
  28. SF Yang, YT Yeh, SN Wang, SC Hung, WT Chen, CH Huang, CY Chai. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma. (Pathology. 2008 Oct; 40(6):558-63.)
  29. HL Chang, JH Su, YT Yeh, YC Lee, HM Chen, YC Wu, SS Yuan. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo. (Cancer Letters. 2008 Aug 18; 267(1):85-95.)
  30. HL Chang, YC Wu, JH Su, YT Yeh, SS Yuan. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 MAPK and JNK1/2. (JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2008 Jun; 325(3):841-9.)
  31. YT Yeh (first author), OY Fu, IF Chen, MF Hou, SS Yuan. Phospho-JAK1 is aberrantly expressed and is associated with estrogen receptor status in breast cancer. (ONCOLOGY REPORTS. 2007 Jan; 17(1):35-9.)
  32. SN Wang, SC Chuang, YT Yeh, SF Yang, CY Chai, WT Chen, KK Kuo, JS Chen, KT Lee. Potential prognostic value of leptin receptor (Ob-R) in hepatocellular carcinoma. (JOURNAL OF CLINICAL PATHOLOGY. 2006 Dec; 59(12):1267-71.)
  33. SF Yang, SS Yuan, YT Yeh, SC Hung, MT Wu, JH Su, CY Chai. Positive association between stat3 and ki-67 in cervical intraepithelial neoplasia. (KAOHSIUNG JOURNAL OF MEDICAL SCIENCES. 2006 Nov; 22(11):539-46.)
  34. SN Wang, YT Yeh, SF Yang, CY Chai, KT Lee. Potential Role of Leptin Expression In Hepatocellular Carcinoma. (JOURNAL OF CLINICAL PATHOLOGY. 2006 Sep; 59(9):930-4.)
  35. SF Yang, SN Wang, YT Yeh, CY Chai, KT Lee. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumor microvessel. (JOURNAL OF CLINICAL PATHOLOGY. 2007 Jun; 60(6):642-8.)
  36. SN Wang, YT Yeh, ML Yu, CL Wang, KT Lee. Serum Adiponectin Between Cholesterol and Pigment Cholelithiasis. (British Journal of Surgery. 2006 Aug; 93(8):981-6.)
  37. DC Chen, YF Chung, YT Yeh, HC Chaung, FC Kuo, OY Fu, HY Chen. Serum adiponectin and leptin levels in Taiwanese breast cancer. (Cancer Letters. 2006 Jun 8; 237(1):109-14.)
  38. YT Yeh (first author), MF Hou, YF Chung, YJ Chen, SF Yang, DC Chen, JH Su, SS Yuan. Decreased expression of phosphorylated JNK in breast infiltrating ductal carcinoma is associated with a better overall survival. (INTERNATIONAL JOURNAL OF CANCER. 2006 Jun 1; 118(11):2678-84.)
  39. YT Yeh (first author), OY Fu, IF Chen, SF Yang, YY Wang, HY Chuang, JH Su, MF Hou, SS Yuan. STAT3 Ser727 Phosphorylation and Its Association with Negative Estrogen Receptor Status in Breast Infiltrating Ductal Carcinoma. (INTERNATIONAL JOURNAL OF CANCER. 2006 Jun 15; 118(12):2943-7.)
  40. TF Chan, JH Su, YF Chung, YH Hsu, YT Yeh, SS Yuan. Elevated amniotic fluid leptin levels in pregnant women who are destined to develop preeclampsia. (Acta Obstetricia et Gynecologica Scandinavica. 2006; 85(2):171-4.)
  41. SN Wang, YT Yeh, ML Yu, WL Chung, KT Lee. Hyperleptinemia and hypoadiponectinemia are associated with gallstone disease. (EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2006 Mar; 36(3):176-80.)
  42. SF Yang, SS Yuan, YT Yeh, MT Wu, JH Su, SC Hung, CY Chai. The role of p-STAT3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial. (GYNECOLOGIC ONCOLOGY. 2005 Sep; 98(3):446-52.)
  43. SS Yuan, KB Tsai, YF Chung, TF Chan, YT Yeh, LY Tsai, JH Su. Aberrant expression and possible involvement of the leptin receptor in endometrial cancer. (GYNECOLOGIC ONCOLOGY. 2004 Mar; 92(3):769-75.)
  44. TF Chan, SS Yuan, HS Chen, CF Guu, LC Wu, YT Yeh, YF Chung, SB Jong, JH Su. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. (Acta Obstetricia et Gynecologica Scandinavica. 2004 Feb; 83(2):165-9.)
  45. TF Chan, JH Su, YF Chung, YH Hsu, YT Yeh, SB Jong, SS Yuan. Amniotic fluid and maternal serum leptin levels in pregnant women who subsequently develop preeclampsia. (European Journal of Obstetrics & Gynecology and Reproductive Biology. 2003 May 1; 108(1):50-3.)
  46. SS Yuan, HL Chang, HW Chen, YT Yeh, YH Kao, KH Lin, YC Wu, JH Su. Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway. (LIFE SCIENCES. 2003 May 9; 72(25):2853-61.)
  47. SS Yuan, YT Yeh, EY Lee. Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1,a Robo member. (Biochemical and Biophysical Research Communications. 2002 Aug 30; 296(4):1019-25.)

【研討會論文】

  1. Inter-alpha-trypsin inhibitor heavy chain-5 (ITIH-5) gene is a potential methylation biomarker in breast cancer. (2014, May) Taiwan Joint Cancer Conference and International Conference of the Asian Clinical Oncology (TJCC & ACOS). Taipei, Taiwan.
  2. Histone deacetylase 6 promotes a ligand-independent activation of EGFR signaling in hepatocellular carcinoma. (2014, Apr) European Association for the Study of the Liver. London, United Kingdom.
  3. Increased pre-mir-133a expression associated with poor prognosis in Taiwanese breast cancer. (2013, Mar) Taiwan Surgical Association. Taipei, Taiwan.
  4. Study the underlying mechanisms and potential roles of activated Mitogen-avtivated Protein Kinase Kinase4 (p-MKK4) in breast cancer metastasis. (2013, Mar) Gallen International Breast Cancer Conference. St. Gallen, Switzerland.
  5. HDAC2 promotes the nuclear the nuclear translocation of HER-2/neu and induced the expression of COX-2 in breast cancer. (2012, Sep) TIBCS & IOPBS. Taipei, Taiwan.
  6. PIAS3 and its interplay with estrogen receptor in breast cancer. (2012, May) EMBO Conference Cellular Signaling & Molecular Medicine. Dubrovnik, Croatia.
  7. Interplay of HDAC6 with progesterone signaling in breast cancer. (2012, May) EMBO Conference Cellular Signaling & Molecular Medicine. Dubrovnik, Croatia.
  8. Novel peptide mimics targeting Nibrin inhibit tumor growth of liver cancer cells. (2012, May) EMBO Conference Cellular Signaling & Molecular Medicine. Dubrovnik, Croatia.
  9. Increased HDAC8 protein associates with poor survival of breast cancer patients. (2012, May) International Symposium on Clinical and Translational Cancer Research. Kaohsiung, Taiwan.
  10. Lignad-like peptide mimic enhanced the cytotoxicity of medroxylprogesterone and mgesterol acetate toward liver cancer cells. (2012, May) International Symposium on Clinical and Translational Cancer Research. Kaohsiung, Taiwan.
  11. The crosstalk of HDAC2 and HER2/neu signaling in breast cancer. (2012, Mar) Taiwan Surgical Association. Taipei, Taiwan.
  12. The Interplay of Methylation of mkp-1 Promoter with Estrogen receptor in Breast Cancer. (2012, Mar) Taiwan Surgical Association. Taipei, Taiwan.
  13. Increased HDAC6 Associated with β-catenin and Poor Prognosis in Hepatocellular Carcinoma. (2011, May) European Biomarkers Summit. London, United Kingdom.
  14. The HDAC9-MEF2 regulatory cycle in metastatic breast cancer. (2010, Dec) San Antonio Breast Cancer Symposia. Texas.
  15. The interplay of HDAC2 with HER2/neu in breast cancer. (2010, Sep) Taipei International Breast Cancer Symposium. Taipei, Taiwan.
  16. Histone deacetylase 6 was associated with overall survival rate in progesterone receptor-negative breast cancer. (2010, Mar) New Paradigms in Cancer Therapeutics (Z1). Victoria, British Columbia.
  17. Molecular pathways and therapeutic targets of adiponectin in Hepatocellular carcinoma. (2010, Mar) New Paradigms in Cancer Therapeutics (Z1). Victoria, British Columbia.